Higher doses of any GLP-1 receptor agonistwhether semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), or tirzepatidecorrelate with increased gastrointestinal adverse events
The tiredness isnt usually a direct effect of the medication itself but rather a result of the rapid changes happening in your body
There is also the risk of long-term bone density loss, possibly resulting in fractured bones
Where the 25% benchmark comes from The benchmark that ~25% of weight lost is FFM under caloric restriction comes from decades of work on diet-induced weight loss
Sattler at Ohio University Heritage College for Osteopathic Medicine, Athens, OH, USA for taking the mouse photograph
Thyroid function, insulin resistance, cortisol levels, and baseline body composition play important roles in early progress